Chenyang Wang
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TPI1 enhances gemcitabine resistance in bladder cancer by promoting autophagy through activating Beclin-1.
Journal: Cell death & disease
Published: July 01, 2025
Targeting PSMB5-induced PANoptosis in bladder cancer: multi-omics insights and TCM candidate discovery.
Journal: Frontiers in immunology
Published: June 30, 2025
TPI1 promotes p53 ubiquitination in bladder cancer by recruiting AKT to enhance MDM2 phosphorylation.
Journal: Pharmacological research
Published: January 21, 2025
Which surgical approach is more favorable for pheochromocytoma of different sizes (< 6 cm vs. ≥ 6 cm)? A single retrospective center experience.
Journal: World journal of surgical oncology
Published: June 15, 2023
COL10A1 as a Prognostic Biomarker in Association with Immune Infiltration in Prostate Cancer.
Journal: Current cancer drug targets
Published: November 16, 2022
Construction of noninvasive prognostic model of bladder cancer patients based on urine proteomics and screening of natural compounds.
Journal: Journal of cancer research and clinical oncology
Published: October 16, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026